ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,428.645
0.27%
Brent Oil
84.015
-0.39%
Bitcoin
64,261.39
-0.93%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) News

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
15/05/202015:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
07/05/202021:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
30/04/202014:23Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
30/04/202014:23Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
30/04/202012:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Period and Eleven Months Ended December 31, 2019, and Operationa...NASDAQ:SMMTSummit Therapeutics Inc
20/04/202021:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
14/04/202022:04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
14/04/202014:15GlobeNewswire Inc.Summit Appoints Robert W. Duggan as Chief Executive OfficerNASDAQ:SMMTSummit Therapeutics Inc
26/03/202019:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
26/02/202021:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
26/02/202012:00GlobeNewswire Inc.Summit Appoints Robert W. Duggan as Executive ChairmanNASDAQ:SMMTSummit Therapeutics Inc
06/02/202021:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/02/202012:00GlobeNewswire Inc.Summit Therapeutics to Receive $1.0 Million Milestone Payment from EurofarmaNASDAQ:SMMTSummit Therapeutics Inc
04/02/202012:00GlobeNewswire Inc.Summit Therapeutics to Present at the 2020 BIO CEO & Investor ConferenceNASDAQ:SMMTSummit Therapeutics Inc
27/01/202021:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
23/01/202022:28Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
23/01/202019:34Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SMMTSummit Therapeutics Inc
23/01/202012:00GlobeNewswire Inc.Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling WorkNASDAQ:SMMTSummit Therapeutics Inc
16/01/202021:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
07/01/202012:00GlobeNewswire Inc.Summit Therapeutics Launches Online Resource for Patients with C. difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
02/01/202021:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SMMTSummit Therapeutics Inc
27/12/201921:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
23/12/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
17/12/201913:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
17/12/201912:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended 31 Octobe...NASDAQ:SMMTSummit Therapeutics Inc
16/12/201914:15GlobeNewswire Inc.Notice of Q3 ResultsNASDAQ:SMMTSummit Therapeutics Inc
10/12/201921:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
06/12/201921:33Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:SMMTSummit Therapeutics Inc
06/12/201914:49Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/12/201912:24GlobeNewswire Inc.Summit Announces a Proposed Subscription and Placing to Raise approximately $50.0 Million and Notice of General MeetingNASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Your Recent History

LSE
TIP5
Ishs $ Tps 0-5
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved